A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Eli Lilly & CO stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 284,907 shares of LLY stock, worth $227 Million. This represents 1.12% of its overall portfolio holdings.

Number of Shares
284,907
Previous 257,327 10.72%
Holding current value
$227 Million
Previous $233 Million 8.34%
% of portfolio
1.12%
Previous 1.17%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$772.14 - $960.02 $21.3 Million - $26.5 Million
27,580 Added 10.72%
284,907 $252 Million
Q2 2024

Jul 30, 2024

SELL
$724.87 - $909.04 $55.5 Million - $69.6 Million
-76,612 Reduced 22.94%
257,327 $233 Million
Q1 2024

May 01, 2024

BUY
$592.2 - $792.28 $21.1 Million - $28.3 Million
35,703 Added 11.97%
333,939 $260 Million
Q4 2023

Jan 24, 2024

SELL
$525.19 - $619.13 $7.86 Million - $9.27 Million
-14,972 Reduced 4.78%
298,236 $174 Million
Q3 2023

Oct 26, 2023

SELL
$434.7 - $599.3 $6.66 Million - $9.19 Million
-15,328 Reduced 4.67%
313,208 $168 Million
Q2 2023

Aug 10, 2023

SELL
$350.74 - $468.98 $25.7 Million - $34.3 Million
-73,225 Reduced 18.23%
328,536 $154 Million
Q1 2023

May 04, 2023

BUY
$310.63 - $364.82 $6.87 Million - $8.07 Million
22,124 Added 5.83%
401,761 $138 Million
Q4 2022

Feb 09, 2023

SELL
$321.55 - $374.67 $23.9 Million - $27.9 Million
-74,382 Reduced 16.38%
379,637 $139 Million
Q3 2022

Nov 10, 2022

SELL
$296.48 - $337.87 $7.53 Million - $8.58 Million
-25,394 Reduced 5.3%
454,019 $148 Million
Q2 2022

Jul 26, 2022

SELL
$278.73 - $327.27 $20.9 Million - $24.5 Million
-74,970 Reduced 13.52%
479,413 $155 Million
Q1 2022

May 10, 2022

SELL
$234.69 - $291.66 $22.8 Million - $28.3 Million
-97,081 Reduced 14.9%
554,383 $159 Million
Q4 2021

Feb 08, 2022

BUY
$224.85 - $279.04 $680,171 - $844,096
3,025 Added 0.47%
651,464 $180 Million
Q3 2021

Nov 15, 2021

BUY
$221.6 - $272.71 $36.2 Million - $44.5 Million
163,338 Added 33.67%
648,439 $150 Million
Q2 2021

Aug 11, 2021

SELL
$180.55 - $233.54 $3.5 Million - $4.53 Million
-19,383 Reduced 3.84%
485,101 $111 Million
Q1 2021

May 13, 2021

BUY
$164.32 - $212.72 $63.3 Million - $82 Million
385,362 Added 323.5%
504,484 $94.2 Million
Q4 2020

Feb 10, 2021

BUY
$130.46 - $172.63 $542,844 - $718,313
4,161 Added 3.62%
119,122 $20.1 Million
Q3 2020

Nov 12, 2020

BUY
$146.22 - $169.13 $6.75 Million - $7.81 Million
46,173 Added 67.12%
114,961 $17 Million
Q2 2020

Aug 11, 2020

BUY
$136.42 - $164.18 $145,150 - $174,687
1,064 Added 1.57%
68,788 $11.3 Million
Q1 2020

May 12, 2020

BUY
$119.05 - $147.35 $1.89 Million - $2.34 Million
15,911 Added 30.71%
67,724 $9.39 Million
Q4 2019

Feb 12, 2020

BUY
$106.92 - $132.43 $984,733 - $1.22 Million
9,210 Added 21.62%
51,813 $6.81 Million
Q3 2019

Nov 12, 2019

BUY
$106.79 - $116.16 $300,934 - $327,338
2,818 Added 7.08%
42,603 $4.77 Million
Q2 2019

Aug 13, 2019

SELL
$110.79 - $129.32 $22.5 Million - $26.3 Million
-203,081 Reduced 83.62%
39,785 $4.41 Million
Q1 2019

May 13, 2019

BUY
$111.31 - $131.02 $19.7 Million - $23.1 Million
176,622 Added 266.62%
242,866 $31.5 Million
Q4 2018

Feb 11, 2019

SELL
$105.9 - $118.64 $1.82 Million - $2.04 Million
-17,161 Reduced 20.58%
66,244 $7.67 Million
Q3 2018

Nov 13, 2018

BUY
$85.86 - $107.31 $534,736 - $668,326
6,228 Added 8.07%
83,405 $8.95 Million
Q2 2018

Aug 14, 2018

SELL
$75.7 - $86.88 $1.49 Million - $1.71 Million
-19,626 Reduced 20.27%
77,177 $6.59 Million
Q1 2018

May 10, 2018

SELL
$74.21 - $87.6 $65,453 - $77,263
-882 Reduced 0.9%
96,803 $7.49 Million
Q4 2017

Feb 12, 2018

SELL
$81.94 - $87.89 $261,552 - $280,544
-3,192 Reduced 3.16%
97,685 $8.25 Million
Q3 2017

Nov 08, 2017

BUY
$77.07 - $85.54 $1.08 Million - $1.2 Million
13,994 Added 16.11%
100,877 $8.63 Million
Q2 2017

Aug 14, 2017

BUY
N/A
86,883
86,883 $7.15 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.